Published in Am J Psychiatry on July 01, 1998
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther (2003) 1.57
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des (2009) 1.51
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag (2007) 1.26
Understanding antipsychotic "atypicality": a clinical and pharmacological moving target. J Psychiatry Neurosci (2003) 1.06
A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia. BMC Psychiatry (2012) 1.02
Pharmacogenetics of antipsychotic-induced side effects. Dialogues Clin Neurosci (2009) 0.92
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol. Psychopharmacology (Berl) (2003) 0.92
An unusual case of hypothermia associated with therapeutic doses of olanzapine: a case report. J Med Case Rep (2011) 0.92
Clinical pharmacology of atypical antipsychotics: an update. EXCLI J (2014) 0.91
Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model. Neuropsychopharmacology (2012) 0.91
Atypicality of atypical antipsychotics. Prim Care Companion J Clin Psychiatry (2005) 0.90
Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. Psychopharmacology (Berl) (2004) 0.89
The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation. Schizophr Res Treatment (2013) 0.88
Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry. Eur J Clin Pharmacol (2008) 0.86
Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? Eur Arch Psychiatry Clin Neurosci (2008) 0.85
Depression and impulsivity as pathways to violence: implications for antiaggressive treatment. Schizophr Bull (2013) 0.85
Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol (Lausanne) (2013) 0.85
Olanzapine induced tardive dystonia. Indian J Pharmacol (2008) 0.85
Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl) (2006) 0.85
Tardive dystonia with olanzapine: a rare case report. Indian J Psychol Med (2012) 0.85
Tardive Meige's syndrome associated with olanzapine. Ann Indian Acad Neurol (2011) 0.85
Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berl) (2003) 0.84
Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response. PLoS One (2012) 0.84
Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology (Berl) (2003) 0.83
Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care. Prim Care Companion J Clin Psychiatry (2000) 0.82
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology (Berl) (2007) 0.81
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl) (2005) 0.81
Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia. Neuropsychiatr Dis Treat (2010) 0.80
Conventional versus novel antipsychotics: changing concepts and clinical implications. J Psychiatry Neurosci (1999) 0.80
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology (Berl) (2005) 0.80
D₂-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D₂-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection. Psychopharmacology (Berl) (2012) 0.79
Molecular imaging as a guide for the treatment of central nervous system disorders. Dialogues Clin Neurosci (2013) 0.79
Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study. Clin Pract Epidemiol Ment Health (2011) 0.79
Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia. Psychopharmacology (Berl) (2008) 0.79
Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications. Int J Bipolar Disord (2016) 0.78
Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems. Curr Neuropharmacol (2015) 0.78
How do the atypical antipsychotics work? J Psychiatry Neurosci (2001) 0.78
Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology (Berl) (2015) 0.78
Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients. Hosp Chron (2015) 0.78
Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology (Berl) (2005) 0.77
Extrastriatal dopamine D(2) receptor occupancy in olanzapine-treated patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.76
Central nervous system drug evaluation using positron emission tomography. Clin Psychopharmacol Neurosci (2011) 0.75
Reappearance of tardive dystonia with olanzapine treated with clozapine. Schizophr Res (2005) 0.75
A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy. Nord J Psychiatry (2017) 0.75
Isolation and localization of DNA segments from specific human chromosomes. Proc Natl Acad Sci U S A (1980) 5.76
A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol (1994) 5.47
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. Proc Natl Acad Sci U S A (1994) 4.48
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44
A primary genetic map of markers of human chromosome 10. Genomics (1988) 4.23
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol (2003) 3.73
Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11. Proc Natl Acad Sci U S A (1984) 3.70
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Role of the SulB (FtsZ) protein in division inhibition during the SOS response in Escherichia coli: FtsZ stabilizes the inhibitor SulA in maxicells. Proc Natl Acad Sci U S A (1985) 3.31
Further changes in differentiation state accompanying the conversion of Chinese hamster cells of fibroblastic form by dibutyryl adenosine cyclic 3':5'-monophosphate and hormones. Proc Natl Acad Sci U S A (1971) 3.23
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry (2001) 3.18
Microsatellite libraries enriched for several microsatellite sequences in plants. Biotechniques (1996) 3.08
Precise localization of human beta-globin gene complex on chromosome 11. Proc Natl Acad Sci U S A (1979) 3.05
Quality of Scottish Morbidity Record (SMR) data. Health Bull (Edinb) (1996) 3.05
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol (1993) 2.92
Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition (1997) 2.92
Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. J Neurosci (1997) 2.85
Recalibration of the delirium prediction model for ICU patients (PRE-DELIRIC): a multinational observational study. Intensive Care Med (2014) 2.71
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2001) 2.69
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry (2000) 2.61
Biosynthesis of vitamin B12: identity of fragment extruded during ring contraction to the corrin macrocycle. Proc Natl Acad Sci U S A (1981) 2.60
Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity (2000) 2.59
Neuroanatomical correlates of encoding in episodic memory: levels of processing effect. Proc Natl Acad Sci U S A (1994) 2.51
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Stimulation of the pre-SMA influences cerebral blood flow in frontal areas involved with inhibitory control of action. Brain Stimul (2013) 2.42
Mammalian cell growth proteins. I. Growth stimulation of fetuin. Proc Natl Acad Sci U S A (1968) 2.40
N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem J (1993) 2.36
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
A fine-structure deletion map of human chromosome 11p: analysis of J1 series hybrids. Somat Cell Mol Genet (1989) 2.29
Partial physical map of human chromosome 21. Somat Cell Mol Genet (1988) 2.27
Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res (1992) 2.25
Neuroanatomical correlates of retrieval in episodic memory: auditory sentence recognition. Proc Natl Acad Sci U S A (1994) 2.23
Seven polymorphic loci mapping to human chromosomal region 11q22-qter. Genomics (1988) 2.23
Novelty and familiarity activations in PET studies of memory encoding and retrieval. Cereb Cortex (1996) 2.22
A rapid method for isolating high quality plasmid DNA suitable for DNA sequencing. Nucleic Acids Res (1990) 2.20
Genetics of somatic mammalian cells: genetic, immunologic, and biochemical analysis with Chinese hamster cell hybrids containing selected human chromosomes. Proc Natl Acad Sci U S A (1976) 2.20
Activation of medial temporal structures during episodic memory retrieval. Nature (1996) 2.17
Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J (1990) 2.17
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry (1999) 2.15
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med (2000) 2.07
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem (1996) 2.06
Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol (1992) 2.01
Atypical antipsychotics. BMJ (2000) 2.01
Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (1986) 2.00
Genetics of somatic mammalian cells: lethal antigens as genetic markers for study of human linkage groups. Proc Natl Acad Sci U S A (1971) 2.00
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J (2013) 2.00
Synteny between glycinamide ribonucleotide synthetase and superoxide dismutase (soluble). Am J Hum Genet (1977) 1.97
Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med (1997) 1.85
Comparative clinical trial of standard operative tracheostomy with percutaneous tracheostomy. Crit Care Med (1991) 1.85
Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry (1996) 1.85
Genetic fine-structure mapping in human chromosome 11 by use of repetitive DNA sequences. Proc Natl Acad Sci U S A (1982) 1.83
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81
Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol (1993) 1.80
High-resolution genotyping of Campylobacter coli identifies clones of epidemiologic and evolutionary significance. J Infect Dis (1995) 1.80
Identification of two human ferritin H genes on the short arm of chromosome 6. Genomics (1990) 1.79
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology (2010) 1.79
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry (1996) 1.76
Inability of the Chemstrip LN compared with quantitative urine culture to predict significant bacteriuria. J Clin Microbiol (1986) 1.75
Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science (1984) 1.75
Comparison of the MicroScan system with the API Staph-Ident system for species identification of coagulase-negative staphylococci. J Clin Microbiol (1986) 1.75
Family physicians for underserved areas. The role of residency training. West J Med (1989) 1.73
A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry (2000) 1.71
Expression and reconstitution of a biologically active human interferon-gamma receptor in hamster cells. J Biol Chem (1990) 1.70
Assignment of the gene coding for the T3-delta subunit of the T3-T-cell receptor complex to the long arm of human chromosome 11 and to mouse chromosome 9. Proc Natl Acad Sci U S A (1985) 1.70
Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy (2008) 1.70
Age-related differences in neural activity during item and temporal-order memory retrieval: a positron emission tomography study. J Cogn Neurosci (2000) 1.69
Measurement of mutagenesis in mammalian cells. Proc Natl Acad Sci U S A (1979) 1.69
Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr (1996) 1.69
Novelty encoding networks in the human brain: positron emission tomography data. Neuroreport (1994) 1.69
Assignment of the gene coding for phosphoribosylglycineamide formyltransferase to human chromosome 14. Somatic Cell Genet (1981) 1.67
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol (2006) 1.63
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr (1997) 1.62
Thyrotoxic vomiting. Br Med J (1976) 1.61
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA (1999) 1.61
Functional role of the prefrontal cortex in retrieval of memories: a PET study. Neuroreport (1995) 1.61
The king's two teeth. Hist Workshop J (2008) 1.60
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry (2001) 1.58
Reminiscence therapy for dementia. Cochrane Database Syst Rev (2005) 1.57
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol (2006) 1.57
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand (2014) 1.56
Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. J Virol (2001) 1.55
L-methionine uptake by human cerebral cortex: maturation from infancy to old age. J Nucl Med (1991) 1.55
A comparative needs assessment of the dental health of adults attending dental access centres and general dental practices in Halton & St Helens and Warrington PCTs 2007. Br Dent J (2009) 1.54
Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am J Hum Genet (1991) 1.52
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell (1990) 1.52
A randomised controlled trial of postal versus interviewer administration of a questionnaire measuring satisfaction with, and use of, services received in the year before death. J Epidemiol Community Health (1998) 1.51
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol (2004) 1.51